Skip to main content

Articles

Page 1 of 84

  1. Cervical cancer (CC) remains a significant global health challenge despite advancements in screening, HPV vaccination, and therapeutic strategies. Tumor heterogeneity, driven by epigenetic modifications, affec...

    Authors: Zhiheng Lin, Youwei Zhou, Zhenran Liu, Wenyang Nie, Hengjie Cao, Shengnan Li, Xuanling Li, Lijun Zhu, Guangyao Lin, Yanyu Ding, Yi Jiang, Zuxi Gu, Lianwei Xu, Zhijie Zhao and Huabao Cai
    Citation: Journal of Experimental & Clinical Cancer Research 2025 44:194
    Content type: Research Published on:

  2. M2 macrophages are known to be involved in tumorigenesis. However, the mechanism by which they promote tumor progression in endometrial cancer (EC) remains largely unknown. Kynureninase (KYNU) has been found t...

    Authors: Xin Pan, Wantong Wang, Yuting Wang, JiaHui Gu and Xiaoxin Ma
    Citation: Journal of Experimental & Clinical Cancer Research 2025 44:193
    Content type: Research Published on:

  3. The adipocyte-rich tumor microenvironment (TME) is recognized as a key factor in promoting cancer progression. A distinct characteristic of peritumoral adipocytes is their reduced lipid content and the acquisi...

    Authors: Dou Yin, Nana Fang, Yaling Zhu, Xiaoqing Bao, Juan Yang, Qingyu Zhang, Ruimeng Wang, Jiahui Huang, Qibing Wu, Fang Ma and Xiaohui Wei
    Citation: Journal of Experimental & Clinical Cancer Research 2025 44:192
    Content type: Research Published on:

  4. Intrinsically resistant glioma stem cells (GSCs) in the setting of a highly immunosuppressive tumor microenvironment (TME) remain the most predominant phenomenon leading to unfavorable therapeutic outcomes in ...

    Authors: Qiong Wu, Jianan Chen, Anders E. Berglund, Dongliang Du, Robert J. Macaulay and Arnold B. Etame
    Citation: Journal of Experimental & Clinical Cancer Research 2025 44:191
    Content type: Research Published on:

  5. Cancer cells uptake excessive nutrients by expressing higher levels of glucose and/or amino acid transporters to meet their increased energy demands. L-type amino acid transporter 1 (LAT1), is regarded as a ca...

    Authors: Margot Y. Fedoroff, Lei Zhao, Shaomin Wang, Alok Bhushan, Haifeng Yang, Karen M. Bussard, Stephen C. Peiper and Jun He
    Citation: Journal of Experimental & Clinical Cancer Research 2025 44:190
    Content type: Research Published on:

  6. In recent years, the development of targeted therapies for tumors with KRAS mutations has progressed rapidly, rendering the notion of KRAS as “undruggable” outdated. However, targeted therapies for KRAS mutati...

    Authors: Shenao Fu, Jiayao Ma, Changjing Cai, Jun Tan, Xiangying Deng, Hong Shen, Shan Zeng, Yihong Chen and Ying Han
    Citation: Journal of Experimental & Clinical Cancer Research 2025 44:189
    Content type: Review Published on:

  7. For patients with prostate cancer (PCa), pelvic lymph node (LN) metastasis remains a major poor prognostic factor associated with cancer-specific mortality. VEGF-C is a major lymphangiogenic ligand that plays ...

    Authors: Tao He, Wen Tao, Jie Zhang, Tao-Lin Xia, Bin Xu and Liao-Yuan Li
    Citation: Journal of Experimental & Clinical Cancer Research 2025 44:188
    Content type: Research Published on:

  8. The current standard therapeutic approach for colorectal cancer (CRC) is surgical operation and oxaliplatin (OXA)-based neoadjuvant chemotherapy. However, the acquisition of oxaliplatin resistance leads to an ...

    Authors: Taixuan Wan, Minyi He, Zhanzhen Liu, Yihang Zhou, Yebohao Zhou, Wei Xiao, Hao Xie, Shuangling Luo, Haoqi Zheng, Liang Kang, Yunxing Shi and Liang Huang
    Citation: Journal of Experimental & Clinical Cancer Research 2025 44:187
    Content type: Research Published on:

  9. Emerging evidence demonstrates that the metabolic and non-metabolic functions of metabolic enzymes play a key role in tumorigenesis and progression. 6-phosphogluconate dehydrogenase (6PGD) is a key metabolic e...

    Authors: Mingming Sun, Qi Yan, Xinru Zhai, Xintong Dai, Chenxin Yang, Huifang Zhao, Sizhen Lai, Jiyan Wang, Lian Li, Zhen Li, Yanping Li, Taoyuan Wang, Tao He, Jun Xue, Zhenghu Jia, Chunze Zhang…
    Citation: Journal of Experimental & Clinical Cancer Research 2025 44:186
    Content type: Research Published on:

  10. Neuroblastoma (NB) is the most common extracranial solid tumor in children characterized by poor immune infiltration and resistance to adaptive immunity, contributing to its limited response to immunotherapy. ...

    Authors: Francesca De Mitri, Manuela Giansanti, Ombretta Melaiu, Dorothee Haas, Stefan Ebert, Nicola Tumino, Elisabetta Vulpis, Francesca Gatto, Beatrice Martuscelli, Manuela Antonioli, Elisabetta Sangiuliano, Simona Caruso, Scarsella Marco, Cristiano De Stefanis, Veronica Marabitti, Silvia Campello…
    Citation: Journal of Experimental & Clinical Cancer Research 2025 44:185
    Content type: Research Published on:

  11. Authors: Jiezhong Guan, Xi Xu, Guo Qiu, Chong He, Xiaoyue Lu, Kang Wang, Xinyu Liu, Yuanyuan Li, Zihang Ling, Xuan Tang, Yujie Liang, Xiaoan Tao, Bin Cheng and Bo Yang
    Citation: Journal of Experimental & Clinical Cancer Research 2025 44:184
    Content type: Correction Published on:

    The original article that this is related to.

  12. Blockade of Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and Programmed Cell Death Protein 1 (PD-1) significantly improves progression-free survival in patients with cancers, including melanoma. In add...

    Authors: Onwodi V. Ifejeokwu, An H. Do, Sanad M. El Khatib, Nhu N. Ho, Angel Zavala, Shivashankar Othy and Munjal M. Acharya
    Citation: Journal of Experimental & Clinical Cancer Research 2025 44:183
    Content type: Research Published on:

  13. 3D-spatial interaction between cancer cells influences tumor behavior, making it essential to replicate tumor structures for predicting patient outcomes.

    Authors: Paloma Navarro, Tatiana P. Grazioso, Arantzazu Barquín, Maria Barba, Mónica Yagüe, Carlos Millán, Irene López, Elena Sevillano, Miguel Quiralte, Paloma Fernández, Diego Losada, Eduardo Caleiras, Julia Calzas, Beatriz Jiménez, Sergio Ruiz-Llorente, Juan Justo…
    Citation: Journal of Experimental & Clinical Cancer Research 2025 44:182
    Content type: Research Published on:

  14. Most cancers, including head and neck squamous cell carcinoma (HNSCC), frequently exhibit an approximately 80% lack of response to immune checkpoint blockade (ICB) therapy, largely attributed to hypoxia-induce...

    Authors: Haoming Zhao, Zhen Zhang, Chaojun Zhang, Hexin Ma, Qingqing Wan, Xinran Zhao, Xu Wang, Ming Yan, Haiyan Guo, Jianjun Zhang and Wantao Chen
    Citation: Journal of Experimental & Clinical Cancer Research 2025 44:181
    Content type: Research Published on:

  16. Authors: Chia-Hung Chien, Wen-Bin Yang, Jian-Ying Chuang, Jung-Shun Lee, Wei-An Liao, Chih-Yuan Huang, Pin-Yuan Chen, An-Chih Wu, Shun-Tai Yang, Chien-Cheng Lai, Pei-I. Chi, Jui-Mei Chu, Siao Muk Cheng, Chan-Chuan Liu, Daw-Yang Hwang, Shang-Hung Chen…
    Citation: Journal of Experimental & Clinical Cancer Research 2025 44:179
    Content type: Correction Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2022 41:220

  17. Atezolizumab (A) plus carboplatin-etoposide (CE) represents the new first-line treatment in extensive stage (ES)-Small Cell Lung Cancer (SCLC) patients. This study aims at identifying the association of baseli...

    Authors: Giulia Pasello, Giulia Pigato, Daniela Scattolin, Stefania Lando, Sara Potente, Chiara Romualdi, Anna Roma, Maria Vittoria Resi, Stefano Frega, Alessandra Ferro, Alessandro Dal Maso, Laura Bonanno, Valentina Guarneri, Elisabetta Lazzarini and Stefano Indraccolo
    Citation: Journal of Experimental & Clinical Cancer Research 2025 44:178
    Content type: Research Published on:

  18. ICC is a malignant tumor that originates from the intrahepatic bile ducts with insidious symptoms and a poor prognosis. Early diagnosis methods and therapeutic targets are urgently needed for ICC.

    Authors: Wenze Wan, Yuan Li, Wentao Sun, Zewei Cheng, Fen Ma, Sheng Shen, Houbao Liu and Jiwei Zhang
    Citation: Journal of Experimental & Clinical Cancer Research 2025 44:177
    Content type: Research Published on:

  19. Diffuse-type gastric cancer (DGC) accounts for approximately one-third of gastric cancer cases, but it is clinically more aggressive and associated with poorer survival prognosis compared to intestinal-type ga...

    Authors: Kang Xu, Hao Chen, Xingyu Zhu, Han Li, Xinyu Liu, Yaodong Sang, Xiaohan Wang, Xiaoling Cui, Baoshan Cai, Liang Shang, Wei Chong and Leping Li
    Citation: Journal of Experimental & Clinical Cancer Research 2025 44:176
    Content type: Research Published on:

  20. Several mechanisms are involved in the resistance to endocrine therapy (ET) in estrogen receptor (ERα)-positive breast cancer (BC), including acquired mutations of ERα gene (ESR1). For example, the frequent mu...

    Authors: Azzurra Zicarelli, Marianna Talia, Muriel Lainé, Rosamaria Lappano, Marcello Maggiolini and Geoffrey L. Greene
    Citation: Journal of Experimental & Clinical Cancer Research 2025 44:175
    Content type: Research Published on:

  21. Epithelial ovarian cancer (EOC) is a leading cause of cancer mortality in women, often diagnosed at advanced stages. While first-line treatments improve survival, relapses remain common, with 5-year survival r...

    Authors: Mehdi Ben Sassi, Henri Azais, Charles Marcaillou, Sylvain Guibert, Emmanuel Martin, Jérôme Alexandre, Louise Benoit, Aurélien de Reynies, Emilie Laude, Cam Duong, Jacques Medioni, Bruno Borghese, Anne-Sophie Bats, Valerie Taly and Pierre Laurent-Puig
    Citation: Journal of Experimental & Clinical Cancer Research 2025 44:174
    Content type: Research Published on:

  22. Chimeric antigen receptor (CAR) T-cell therapy has shown limited efficacy in glioblastoma (GBM) due to tumor antigen heterogeneity and the immunosuppressive microenvironment. To address these barriers, we deve...

    Authors: Sheng Fang, Jiankun Wu, Yida Liu, Peiwen Wang, Guiqiang Yuan, Jiajia Gao, Wenxin Zhang, Junwen Zhang and Fusheng Liu
    Citation: Journal of Experimental & Clinical Cancer Research 2025 44:173
    Content type: Research Published on:

  23. Colorectal cancer (CRC) is a common and aggressive malignancy that frequently metastasizes to the liver, presenting significant therapeutic challenges. Despite its clinical importance, the mechanisms underlyin...

    Authors: Zizhen Zhang, Shengde Liu, Ting Xu, Nan Chen, Cheng Liu, Hong Yang, Yuanmeng Shi, Zhiwei Li, Xujiao Feng, Yanhong Yao, Xiaorui Duan, Gehan Xu, Cheng Zhang, Zhenghang Wang, Jian Li and Lin Shen
    Citation: Journal of Experimental & Clinical Cancer Research 2025 44:172
    Content type: Research Published on:

  24. Cancer is one of the deadliest diseases, continually prompting physicians and researchers to investigate safe and effective modalities for its treatment. Piezoelectric nanomaterial is a new class of material w...

    Authors: Tingting Zuo, Saikat Dewanjee, Chao Zhang, Pratik Chakraborty, Wanxia Lu, Niraj Kumar Jha, Hiranmoy Bhattacharya, Moumita Gangopadhyay, Joshua Fleishman, Saurabh Kumar Jha and Zhe-Sheng Chen
    Citation: Journal of Experimental & Clinical Cancer Research 2025 44:171
    Content type: Research Published on:

  25. Drug resistance and relapse are still major challenges in acute myeloid leukemia (AML) because of the inability to effectively eradicate leukemia stem cells (LSCs). Senescence induction combined with immune ki...

    Authors: Xiao Ma, Yingnan Li, Di Wang, Jialan Niu, Qian Li, Ying Chen, Mengyuan Wang, Jin Wen, Chenxi Liao, Nan Wang, Xiaolan Zhang, Jiwei Chang, Jiayi Yang, Lei Li, Jing Zou, Danyue Peng…
    Citation: Journal of Experimental & Clinical Cancer Research 2025 44:170
    Content type: Research Published on:

  27. Low-dose computed tomography (LDCT) lung cancer screening can reduce mortality in high-risk individuals, but many individuals with a heavy smoking history may be reluctant to undergo radiologic examinations. A...

    Authors: Gabriella Sozzi, Federica Sabia, Luigi Rolli, Miriam Segale, Paola Suatoni, Anna Zanghi, Margherita Ruggirello, Alfonso Marchianò, Mattia Boeri and Ugo Pastorino
    Citation: Journal of Experimental & Clinical Cancer Research 2025 44:168
    Content type: Comment Published on:

  28. Chromodomain Helicase DNA-binding protein 1-Like (CHD1L) is a chromatin remodeling enzyme increasingly recognized as an oncogenic factor promoting tumor progression and metastatic potential by orchestrating tr...

    Authors: Sophia Clune, Paul Awolade, Hector Esquer, Qiong Zhou and Daniel V. LaBarbera
    Citation: Journal of Experimental & Clinical Cancer Research 2025 44:167
    Content type: Comment Published on:

  29. Authors: Canio Martinelli, Alfredo Ercoli, Giuseppe Vizzielli, Sharon Raffaella Burk, Maria Cuomo, Vrunda Satasiya, Housem Kacem, Simone Braccia, Giulio Mazzarotti, Irene Miriello, Manuela Nana Tchamou, Stefano Restaino, Martina Arcieri, Alice Poli, Veronica Tius, Silvana Parisi…
    Citation: Journal of Experimental & Clinical Cancer Research 2025 44:166
    Content type: Correction Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2025 44:140

  30. Authors: Lorenzo Castagnoli, Alma Franceschini, Valeria Cancila, Matteo Dugo, Martina Bigliardi, Claudia Chiodoni, Paolo Toneguzzo, Viola Regondi, Paola A. Corsetto, Filippo Pietrantonio, Serena Mazzucchelli, Fabio Corsi, Antonino Belfiore, Andrea Vingiani, Giancarlo Pruneri, Francesca Ligorio…
    Citation: Journal of Experimental & Clinical Cancer Research 2025 44:165
    Content type: Correction Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2025 44:19

  31. Branched-chain amino acid (BCAA) metabolism is dysregulated in colorectal cancer (CRC), with elevated plasma BCAA levels significantly associated with an increased risk of developing the disease. However, whet...

    Authors: Zhenkang Li, Zhengyu Liu, Mingdao Lin, Huayang Pan, Yuechen Liu, Yang Liu, Yuwen Xie, Jinchao Zhang, Shenyuan Guan, Yongsheng Li, Mulan Zhu, Yuan Fang, Zhiyong Shen and Haijun Deng
    Citation: Journal of Experimental & Clinical Cancer Research 2025 44:164
    Content type: Research Article Published on:

  32. Melanoma brain metastases (MBM) are a leading cause of death in patients with advanced disease. MBM treatment relay on targeted and immunotherapy and on stereotactic radiosurgery as gold standard. Life expecta...

    Authors: Varsha Thakur, Vijay S. Thakur, Dazhi Wang, Juliano Tiburcio de Freitas, Anna Bianchi, Luis Alberto Nivelo, Oliver Umland, Scott M. Welford and Barbara Bedogni
    Citation: Journal of Experimental & Clinical Cancer Research 2025 44:163
    Content type: Research Published on:

  33. Meningiomas are the most common primary intracranial tumours, with clinical behaviours ranging from benign to highly aggressive forms. The World Health Organisation classifies meningiomas into various grades, ...

    Authors: Ting Zhang, Claire L. Adams, Gyorgy Fejer, Emanuela Ercolano, Jonathan Cutajar, Juri Na, Felix Sahm and C. Oliver Hanemann
    Citation: Journal of Experimental & Clinical Cancer Research 2025 44:162
    Content type: Research Published on:

  34. Adenosine signaling pathway is a kind of signal regulation hub widely existing in human body, which is involved in a series of physiological processes such as energy supply of body cells. CD73 is a highly conc...

    Authors: Liang Shan, Mingxu Gong, Dandan Zhai, Xiangyun Meng, Jianjun Liu and Xiongwen Lv
    Citation: Journal of Experimental & Clinical Cancer Research 2025 44:161
    Content type: Review Published on:

  35. Authors: Bixing Zhao, Yang Zhou, Niangmei Cheng, Xiaoyuan Zheng, Geng Chen, Xin Qi, Xiangzhi Zhang, Fei Wang, Qiuyu Zhuang, Yehuda G. Assaraf, Xiaolong Liu, Yingchao Wang and Yongyi Zeng
    Citation: Journal of Experimental & Clinical Cancer Research 2025 44:160
    Content type: Correction Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2025 44:139

  36. The prognosis of osteosarcoma has improved little over the past few decades, with radioresistance being a contributing factor. Effective radiosensitizing targets and novel mechanisms for treating osteosarcoma ...

    Authors: Qiujian Lian, Hu Liu, Jingyan Li, Cheng Luo, Chang Liu, Haonan Zhao, Peijun Dai, Bingxuan Wang, Huipeng Zhou, Xin Jiang, Zhiwei Wang and Suchi Qiao
    Citation: Journal of Experimental & Clinical Cancer Research 2025 44:159
    Content type: Research Published on:

  37. Pancreatic cancer is one of the most difficult to treat neoplasias. Because of that, the prognosis of the disease is dismal, and identification of novel therapeutic approaches is needed. This study investigate...

    Authors: Inés Romero-Pérez, Juan Carlos Montero, Mónica Redondo-Puente, María del Carmen Gómez-García, Mireia Morell-Ginestà, Gabriel Capellá and Atanasio Pandiella
    Citation: Journal of Experimental & Clinical Cancer Research 2025 44:158
    Content type: Research Published on:

  38. While primary breast cancer (BC) is often effectively managed, metastasis remains the primary cause of BC-related fatalities. Gaps remain in our understanding of the mechanisms regulating cancer cell organotro...

    Authors: Amélie Nadeau, Thupten Tsering, Mohamed Abdouh, Laura Kienzle, Jenna Cleyle, Lorne Taylor, Noélie Douanne, Kyle Dickinson, Peter M. Siegel and Julia V. Burnier
    Citation: Journal of Experimental & Clinical Cancer Research 2025 44:157
    Content type: Research Published on:

  39. Authors: Klaus Pantel, Catherine Alix-Panabières, Paul Hofman, Nikolas H. Stoecklein, Yong-Jie Lu, Evi Lianidou, Patrizio Giacomini, Claudia Koch, Vincent de Jager, Zandra C. Deans, Jennifer Fairley, Simon J. Patton, Rodrigo A. Toledo, Ed Schuuring, Ellen Heitzer, An Hendrix…
    Citation: Journal of Experimental & Clinical Cancer Research 2025 44:156
    Content type: Meeting Report Published on:

  40. HBV integration is considered as the main contributor to hepatocellular carcinoma (HCC). However, whether HBV integrated sequences determine genotype pathogenicity and how to block their function during HCC pr...

    Authors: Lu Chen, Wenxuan Li, Wenjing Zai, Xiangyi Zheng, Xianlong Meng, Qunyan Yao, Wei Li, Ying Liang, Mu Ye, Kaicheng Zhou, Mengxing Liu, Zhicong Yang, Zhanrui Mao, Hongyan Wei, Shuai Yang, Guoming Shi…
    Citation: Journal of Experimental & Clinical Cancer Research 2025 44:155
    Content type: Research Published on:

  41. Non-small cell lung cancer (NSCLC) is a significant global health challenge, with 2% of cases fuelled by RET rearrangements. RET inhibitors (RETi) have revolutionized treatment for these patients, but resistance ...

    Authors: Daniela Esposito, Claudia Maria Ascione, Stefania Belli, Fabiana Napolitano, Alberto Servetto, Felice Pepe, Umberto Malapelle, Antonino Iaccarino, Giancarlo Troncone, Diletta Barone, Emilio Bria, Roberto Ferrara, Daniele Lorenzini, Giuseppe Lo Russo, Maria Rosa Ghigna, Arianna Marinello…
    Citation: Journal of Experimental & Clinical Cancer Research 2025 44:154
    Content type: Research Published on:

  42. Hepatocellular carcinoma (HCC) is a highly aggressive malignancy with limited treatment options in advanced stages. While c-Met is a promising therapeutic target in HCC, identifying patients who will benefit f...

    Authors: Xubo Huang, Runya Fang, Yuqian Pang, Zhe Zhang, Jieru Huang, Yingchang Li, Tao Yuan, Yuyi Zeng, Ziying Yao, Silvia Vega-Rubín-de-Celis, Josephine Thinwa, Qisheng Zhang, Hao Shen, Jiahong Wang, Feng Shen and Yongjie Wei
    Citation: Journal of Experimental & Clinical Cancer Research 2025 44:153
    Content type: Research Published on:

  44. Intrahepatic cholangiocarcinoma (ICC) is a malignant tumor with a poor prognosis, marked by a postoperative recurrence rate of 50–60% and a 5-year survival rate of 8–30%. Abnormal tumor metabolism, particularl...

    Authors: Yanyu Gong, Liwen Chen, Hao Wang, Dijie Zheng, Futang Li, Changhao Wu, Yongning Li, Yazhu Deng, Zhiwei He and Chao Yu
    Citation: Journal of Experimental & Clinical Cancer Research 2025 44:151
    Content type: Research Published on:

  45. Serous endometrial cancer (SEC) is a genomically and morphologically distinct endometrial cancer (EC) subtype with a poor progression-free and overall survival. The development of novel therapies is needed to ...

    Authors: Xiaonan Hou, Valentina Zanfagnin, Conway Xu, Erik Jessen, Yuanhang Liu, Chen Wang, Yajue Huang, Shaun D. Fontaine, Daniel V. Santi, Gerardo Colon-Otero, Sarah E. Gill, Gretchen E. Glaser, Kristina A. Butler, Jamie N. Bakkum-Gamez, Sean C. Dowdy, Ann L. Oberg…
    Citation: Journal of Experimental & Clinical Cancer Research 2025 44:150
    Content type: Research Published on:

  46. Copper accumulation triggers mitochondrial-driven cell death, known as cuproptosis, offering a promising mechanism for targeted cancer therapy. Recent studies have highlighted the critical role of intratumoral...

    Authors: Pengyu Wang, Weihua Guo, Shuyue Liu, Shouyi Li, Jiaqi Li, Bowen Ding, Fengyi Yin, Yang Yang, Xingjiang Li, Pei Cao, Chaozhe Ma, Wanying Zhang, Yidan Song, Yating Geng, Lantao Liu, Jing Hu…
    Citation: Journal of Experimental & Clinical Cancer Research 2025 44:149
    Content type: Research Published on:

  47. Immunotherapy, notably the immune checkpoint blockade (ICB), has demonstrated significant promise in the management of diverse neoplasms. However, the PD-1 inhibitor has exhibited suboptimal objective response...

    Authors: Hai Xu, Shuo Li, Yifan Liu, Yoon-Young Sung, Yong Zhou and Huikun Wu
    Citation: Journal of Experimental & Clinical Cancer Research 2025 44:148
    Content type: Research Published on:

  48. Although tumor immunotherapy has emerged as a promising treatment modality, it faces significant challenges stemming from the immunosuppressive characteristics of the tumor microenvironment (TME), the low immu...

    Authors: Chuan Wu, Mingquan Gao, Weidong Xiao, Xie Huang, Xinrui Yang, Zifei Wu, Xudong Yu, Banghui Mo, Zaizhi Du, Ziqian Shang, Jing Liu, Can Shi, Rong Li, Shenglin Luo and Weidong Wang
    Citation: Journal of Experimental & Clinical Cancer Research 2025 44:147
    Content type: Research Published on:

  49. Complex host-virus interactions account for adaptive and innate immunity dysfunctions and viral cccDNA mini-chromosome persistence, key features of HBV chronicity and challenges for HBV cure. The extent of HBV...

    Authors: Vincenzo Alfano, Giuseppe Rubens Pascucci, Giacomo Corleone, Massimiliano Cocca, Francesca De Nicola, Océane Floriot, Alexia Paturel, Francesca Casuscelli Di Tocco, Claude Caron de Fromentel, Philippe Merle, Michel Rivoire, Massimo Levrero and Francesca Guerrieri
    Citation: Journal of Experimental & Clinical Cancer Research 2025 44:146
    Content type: Research Published on:

  50. Despite the significant advances in the development of immune checkpoint inhibitors (ICI), primary and acquired ICI resistance remains the primary impediment to effective cancer immunotherapy. Residing in the ...

    Authors: Yan Yang, Sijia Li, Kenneth K.W. To, Shuangli Zhu, Fang Wang and Liwu Fu
    Citation: Journal of Experimental & Clinical Cancer Research 2025 44:145
    Content type: Review Published on:

Annual Journal Metrics

  • Citation Impact 
    Journal Impact Factor: 12.8 (2024)    
    5-year Journal Impact Factor: 12.2 (2024)    
    Source Normalized Impact per Paper (SNIP): 2.009 (2024)    
    SCImago Journal Rank (SJR): 3.328 (2024)

    Speed 
    Submission to first editorial decision (median days): 2
    Submission to acceptance (median days): 96

    Usage 2024
    Downloads: 4,059,655
    Altmetric mentions: 2,197

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us